We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $494K invested in Sage Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 185 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

77.93% less ownership

Funds ownership: 78.02% → 0.09% (-78%)

97% less funds holding

Funds holding: 191 → 5 (-186)

100% less capital invested

Capital invested by funds: $446M → $494K (-$445M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 185

Holders
5
Holders Change
-186
Holders Change %
-97.38%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
185
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$150K
2
IA
IFP Advisors
Florida
+$45

Top Sellers

Rank Fund Capital Flow
1
MAP
Madison Avenue Partners
New York
-$55.4M
2
BlackRock
BlackRock
New York
-$41.5M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$29.8M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$17.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$17.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
BGIM
26
Boussard & Gavaudan Investment Management
United Kingdom
– -$5.61M -614,939 Closed
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
– -$5.31M -581,753 Closed
N
28
Nuveen
North Carolina
– -$5.06M -555,036 Closed
Morgan Stanley
29
Morgan Stanley
New York
– -$4.83M -529,376 Closed
Goldman Sachs
30
Goldman Sachs
New York
– -$4.73M -519,107 Closed
Northern Trust
31
Northern Trust
Illinois
– -$4.22M -462,585 Closed
Charles Schwab
32
Charles Schwab
California
– -$4.18M -458,248 Closed
GCL
33
Glazer Capital LLC
New York
– -$4.02M -441,108 Closed
OAC
34
OMERS Administration Corp
Ontario, Canada
– -$3.87M -424,300 Closed
AA
35
AQR Arbitrage
Connecticut
– -$3.73M -409,055 Closed
MAM
36
Monaco Asset Management
Monaco
– -$3.34M -366,619 Closed
HF
37
HRT Financial
New York
– -$3.02M -330,661 Closed
ECM
38
Eisler Capital Management
United Kingdom
– -$3.01M -330,150 Closed
YIH
39
Y-Intercept (HK)
Hong Kong
– -$2.77M -303,888 Closed
BCM
40
BCK Capital Management
Connecticut
– -$2.71M -297,040 Closed
JF
41
Jump Financial
Illinois
– -$2.64M -289,341 Closed
Two Sigma Investments
42
Two Sigma Investments
New York
– -$2.44M -268,007 Closed
Federated Hermes
43
Federated Hermes
Pennsylvania
– -$2.25M -246,804 Closed
GCIA
44
Gabelli & Co Investment Advisers
New York
– -$2.05M -224,450 Closed
TI
45
Trexquant Investment
Connecticut
– -$2.03M -223,121 Closed
Deutsche Bank
46
Deutsche Bank
Germany
– -$1.97M -215,905 Closed
GF
47
Gabelli Funds
New York
– -$1.83M -200,777 Closed
Invesco
48
Invesco
Georgia
– -$1.83M -200,332 Closed
Two Sigma Advisers
49
Two Sigma Advisers
New York
– -$1.81M -198,799 Closed
SFI
50
Susquehanna Fundamental Investments
Pennsylvania
– -$1.79M -196,284 Closed
1
2
3 4 5

SAGE Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2025, worth a combined $494K — down 100% from $446M a quarter earlier.

Sellers outnumbered buyers: 185 funds closed out of SAGE and 0 opened new positions — a net loss of 185 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $150K. The largest seller was Madison Avenue Partners, exiting entirely with an estimated $55.4M sold.

  • 5 institutional investors held Sage Therapeutics (SAGE) as of Q3 2025, down from 191 in Q2 2025.
  • Funds reported $494K of Sage Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Sage Therapeutics positions in Q3 2025 and 185 closed out, a net change of -185 holders.
  • The largest Sage Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $150K added.
  • The largest Sage Therapeutics seller in Q3 2025 was Madison Avenue Partners, an estimated $55.4M sold.

Based on aggregated 13F filings for Q3 2025.